BioTech Medics, Inc. (BMCS)
USD 0.01
(-15.15%)
USD 0.01
(-15.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 28.32 Thousand | 115.14 Thousand | 322.56 Thousand | 154.22 Thousand | 61.4 Thousand | - |
| Selling, General and Administrative Expenses | 28.32 Thousand | 115.14 Thousand | 322.56 Thousand | 154.22 Thousand | 61.4 Thousand | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 28.32 Thousand | 115.14 Thousand | 322.56 Thousand | 154.22 Thousand | 61.4 Thousand | - |
| Operating Income | -28.32 Thousand | -115.15 Thousand | -322.56 Thousand | -154.23 Thousand | -61.4 Thousand | - |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -167.89 Thousand | -228.48 Thousand | -236.55 Thousand | -206.29 Thousand | -171.86 Thousand | - |
| Earnings before Tax | -5624.00 | -115.14 Thousand | -322.56 Thousand | -109.67 Thousand | -61.4 Thousand | - |
| Net Income | -5624.00 | -115.14 Thousand | -322.56 Thousand | -109.67 Thousand | -61.4 Thousand | - |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5624.00 | -115.15 Thousand | -322.56 Thousand | -109.67 Thousand | -61.4 Thousand | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 11.96 Thousand | 12.52 Thousand | 28.32 Thousand | 16.8 Thousand | 6531.00 | 2581.00 |
| Selling, General and Administrative Expenses | 11.96 Thousand | 12.52 Thousand | - | 16.8 Thousand | 6531.00 | 2581.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 11.96 Thousand | 12.52 Thousand | 28.32 Thousand | 16.8 Thousand | 6531.00 | 2581.00 |
| Operating Income | -11.96 Thousand | -12.52 Thousand | -28.32 Thousand | -16.81 Thousand | -6530.00 | -2580.00 |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -43.27 Thousand | -167.89 Thousand | -43.81 Thousand | 39.58 Thousand | -122.08 Thousand |
| Earnings before Tax | -6021.00 | -12.52 Thousand | -5624.00 | 5894.00 | -6531.00 | -2581.00 |
| Net Income | -6021.00 | -12.52 Thousand | -5624.00 | 5894.00 | -6531.00 | -2581.00 |
| Earnings Per Share Basic | - | -0.00 | - | - | - | - |
| Earnings Per Share Diluted | - | -0.00 | - | - | - | - |
| Weighted Average Shares Outstanding | 205.35 Million | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 205.35 Million | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million | 202.35 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -11.96 Thousand | -12.52 Thousand | - | -16.81 Thousand | -6530.00 | -2580.00 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
OSUKF
600193
8171
USEG
PBRX
7293